Research & Development

Pharmaceutical manufacturers are implementing comprehensive sustainability strategies to achieve net-zero manufacturing objectives including energy optimization, waste-reduction technologies, solvent recovery systems, and sustainable facility designs. This article examines how pharmaceutical companies balance environmental responsibility objectives with product quality assurance and regulatory compliance obligations, explores emerging green technologies reshaping facility operations, and analyzes how sustainability leadership strengthens competitive positioning while advancing environmental objectives.

Eli Lilly and Company has entered a five-year collaboration with Indiana University that will provide up to $40 million to expand clinical trial access...

Mount Sinai obstetricians have become the first in New York City to use FDA-cleared artificial intelligence technology designed to enhance prenatal ultrasound evaluations for...

New clinical data on breast cancer detection tech from Hologic is going to be presented at the Scientific Assembly and Annual Meeting of the...

Emerging markets—encompassing Asia-Pacific, Latin America, and the Middle East—have emerged as increasingly important centers for clinical research and drug development. This geographic shift reflects...

Modern biomanufacturing facilities represent the convergence of advanced automation, sophisticated digital systems, and environmental stewardship principles. Next-generation facilities fundamentally differ from traditional pharmaceutical plants...

The contract development and manufacturing organization (CDMO) sector is experiencing unprecedented growth as pharmaceutical companies fundamentally reassess their manufacturing strategies. Once viewed as a...